Diabetes Insipidus, Nephrogenic
"Diabetes Insipidus, Nephrogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or aquaporin-2 (AQUAPORINS); KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.
MeSH Number(s)
C12.777.419.135.500
C13.351.968.419.135.500
Concept/Terms
Nephrogenic Diabetes Insipidus, Type I- Nephrogenic Diabetes Insipidus, Type I
- Diabetes Insipidus, Nephrogenic, X-Linked
- Diabetes Insipidus, Nephrogenic, Type 1
- Diabetes Insipidus, Nephrogenic, Type I
Below are MeSH descriptors whose meaning is more general than "Diabetes Insipidus, Nephrogenic".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Insipidus, Nephrogenic".
This graph shows the total number of publications written about "Diabetes Insipidus, Nephrogenic" by people in Harvard Catalyst Profiles by year, and whether "Diabetes Insipidus, Nephrogenic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Diabetes Insipidus, Nephrogenic" by people in Profiles.
-
Aquaporins in Diabetes Insipidus. Adv Exp Med Biol. 2023; 1398:267-279.
-
A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner. J Clin Endocrinol Metab. 2022 05 17; 107(6):e2513-e2522.
-
Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus. JCI Insight. 2020 01 16; 5(1).
-
Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet. 2019 08 17; 394(10198):587-595.
-
Lithium-Induced Nephropathy. N Engl J Med. 2018 Mar 15; 378(11):1042.
-
RNA editing with CRISPR-Cas13. Science. 2017 11 24; 358(6366):1019-1027.
-
Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus. N Engl J Med. 2016 11 17; 375(20):2008-2009.
-
Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis. Am J Kidney Dis. 2017 Feb; 69(2):317-319.
-
Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus. PLoS One. 2014; 9(7):e101753.
-
Ifosfamide-induced Fanconi syndrome and desmopressin-responsive nephrogenic diabetes insipidus. Am J Med. 2013 Jul; 126(7):e7-8.